BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28517336)

  • 1. SU-E-T-263: Luminescent Dosimetry to Measure the Out-Of-Field Low and High LET Dose Components in High Energy Photon and Proton Therapy Beams.
    Reft C
    Med Phys; 2012 Jun; 39(6Part13):3764. PubMed ID: 28517336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
    Reft CS; Runkel-Muller R; Myrianthopoulos L
    Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The energy dependence and dose response of a commercial optically stimulated luminescent detector for kilovoltage photon, megavoltage photon, and electron, proton, and carbon beams.
    Reft CS
    Med Phys; 2009 May; 36(5):1690-9. PubMed ID: 19544786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV).
    Tedgren AC; Hedman A; Grindborg JE; Carlsson GA
    Med Phys; 2011 Oct; 38(10):5539-50. PubMed ID: 21992372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs.
    Chibani O; Ma CM
    Med Phys; 2003 Aug; 30(8):1990-2000. PubMed ID: 12945965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of absorbed dose to water around a clinical HDR (192)Ir source using LiF:Mg,Ti TLDs demonstrates an LET dependence of detector response.
    Carlsson Tedgren A; Elia R; Hedtjarn H; Olsson S; Alm Carlsson G
    Med Phys; 2012 Feb; 39(2):1133-40. PubMed ID: 22320824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of TLD-100 in mixed fields of photons and electrons.
    Lawless MJ; Junell S; Hammer C; DeWerd LA
    Med Phys; 2013 Jan; 40(1):012103. PubMed ID: 23298105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.
    De Saint-Hubert M; Verbeek N; Bäumer C; Esser J; Wulff J; Nabha R; Van Hoey O; Dabin J; Stuckmann F; Vasi F; Radonic S; Boissonnat G; Schneider U; Rodriguez M; Timmermann B; Thierry-Chef I; Brualla L
    Front Oncol; 2022; 12():882489. PubMed ID: 35756661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of stray radiation within a scanning proton therapy facility: EURADOS WG9 intercomparison exercise of active dosimetry systems.
    Farah J; Mares V; Romero-Expósito M; Trinkl S; Domingo C; Dufek V; Klodowska M; Kubancak J; Knežević Ž; Liszka M; Majer M; Miljanić S; Ploc O; Schinner K; Stolarczyk L; Trompier F; Wielunski M; Olko P; Harrison RM
    Med Phys; 2015 May; 42(5):2572-84. PubMed ID: 25979049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic out-of-field secondary neutron spectrometry and dosimetry in pencil beam scanning proton therapy.
    Trinkl S; Mares V; Englbrecht FS; Wilkens JJ; Wielunski M; Parodi K; Rühm W; Hillbrand M
    Med Phys; 2017 May; 44(5):1912-1920. PubMed ID: 28294362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SU-E-T-137: The Response of TLD-100 in Mixed Fields of Photons and Electrons.
    Lawless M; Junell S; Hammer C; DeWerd L
    Med Phys; 2012 Jun; 39(6Part11):3734. PubMed ID: 28517172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs.
    Kry SF; Alvarez P; Cygler JE; DeWerd LA; Howell RM; Meeks S; O'Daniel J; Reft C; Sawakuchi G; Yukihara EG; Mihailidis D
    Med Phys; 2020 Feb; 47(2):e19-e51. PubMed ID: 31574174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of nanoDot optically stimulated luminescence detectors and high-sensitivity MCP-N thermoluminescent detectors in the 40-300 kVp energy range.
    Poirier Y; Kuznetsova S; Villarreal-Barajas JE
    Med Phys; 2018 Jan; 45(1):402-413. PubMed ID: 29164632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of LiF:Mg,Ti thermoluminescence detectors in low-LET proton beams at ultra-high dose rates.
    Motta S; Christensen JB; Togno M; Schäfer R; Safai S; Lomax AJ; Yukihara EG
    Phys Med Biol; 2023 Feb; 68(4):. PubMed ID: 36696696
    [No Abstract]   [Full Text] [Related]  

  • 15. Using LiF:Mg,Cu,P TLDs to estimate the absorbed dose to water in liquid water around an 192Ir brachytherapy source.
    Lucas PA; Aubineau-Lanièce I; Lourenço V; Vermesse D; Cutarella D
    Med Phys; 2014 Jan; 41(1):011711. PubMed ID: 24387503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating dose to implantable cardioverter-defibrillator outside the treatment fields using a skin QED diode, optically stimulated luminescent dosimeters, and LiF thermoluminescent dosimeters.
    Chan MF; Song Y; Dauer LT; Li J; Huang D; Burman C
    Med Dosim; 2012; 37(3):334-8. PubMed ID: 22296877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary neutron spectrum from 250-MeV passively scattered proton therapy: measurement with an extended-range Bonner sphere system.
    Howell RM; Burgett EA
    Med Phys; 2014 Sep; 41(9):092104. PubMed ID: 25186404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of neutron contamination on dosimetry in external photon beam radiotherapy.
    Horst F; Czarnecki D; Zink K
    Med Phys; 2015 Nov; 42(11):6529-36. PubMed ID: 26520743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
    Vynckier S; ;
    Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of optically stimulated luminescence dosimeters in the spread-out Bragg peak region of clinical proton beams.
    Kerns JR; Kry SF; Sahoo N
    Med Phys; 2012 Apr; 39(4):1854-63. PubMed ID: 22482607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.